{"id":"W2169039067","doi":"10.1158/1078-0432.ccr-13-2293","title":"Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Erlotinib; Vandetanib; Gemcitabine; Gefitinib; Cytotoxicity; Pharmacology; Cabozantinib; Medicine; Nucleoside; Cancer research; Cancer; Chemistry; Internal medicine; In vitro; Epidermal growth factor receptor; Hepatocellular carcinoma; Sorafenib; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001749587,0.0003879827,0.0004875666,0.000252572,0.0001512127,0.0004374989,0.0002102538,0.0003032904,0.000888564],"category_scores_gemma":[0.0001623559,0.0001480967,0.0002791849,0.0002606321,0.0001568989,0.0001843037,0.0001390594,0.0002877223,0.0003379261],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005301324,"about_ca_system_score_gemma":0.000342573,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001549797,"about_ca_topic_score_gemma":0.003159106,"domain_scores_codex":[0.999801,0.00003620209,0.00002502223,0.00003742844,0.00005670902,0.00004369306],"domain_scores_gemma":[0.9999368,0.00000912032,0.00002230813,0.000007921349,0.00001115124,0.00001258382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006396883,0.0001438216,0.001243046,0.0001424501,0.00004206655,0.00006818918,0.00002238287,0.0006200421,0.982285,0.0001361735,0.0002944954,0.01436254],"study_design_scores_gemma":[0.000154161,0.001382681,0.01032417,0.00001200647,0.000048699,0.000702829,0.00002537605,0.001706508,0.9765664,0.00003551416,0.009029962,0.00001177661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9826151,0.01092825,0.002294017,0.000154191,0.00003838731,0.0000670406,0.0005421797,0.0001822825,0.003178409],"genre_scores_gemma":[0.9921752,0.002785883,0.002018097,0.0000536476,0.000009877607,0.0000538167,0.000940096,0.00002000963,0.00194326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001549797,"threshold_uncertainty_score":0.003846467,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1048941416274085,"score_gpt":0.4375857204330001,"score_spread":0.3326915788055916,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}